Related Experiment Videos
[Anticoagulation as an oncological therapy principle]
M Stockschläder1, F Wenzel, R B Zotz
1Institut für Hämostaseologie und Transfusionsmedizin, Heinrich-Heine-Universität Düsseldorf. stockschlaeder@med.uni-duesseldorf.de
Deutsche Medizinische Wochenschrift (1946)
|January 29, 2005
Summary
Anticoagulation in cancer patients may prevent blood clots and potentially inhibit tumor growth and metastasis. Clinical studies suggest anticoagulation therapy could improve survival for select cancer patients.
Area of Science:
- Oncology
- Hematology
- Thrombosis
Context:
- The link between cancer and thromboembolic events is well-established.
- Emerging evidence suggests hemostasis factors influence tumor progression.
- Neoplastic thrombogenesis and tumor-associated thrombophilia are partially understood.
Purpose:
- To explore the dual role of anticoagulation in cancer care.
- To investigate the potential antineoplastic and antimetastatic effects of anticoagulation.
- To assess the impact of anticoagulation on cancer patient survival.
Summary:
- Anticoagulation in cancer patients may offer benefits beyond preventing thromboembolic complications.
- Factors in blood coagulation appear to promote tumor growth, angiogenesis, and metastasis.
- Pharmacological anticoagulation might possess antineoplastic and antimetastatic properties.
Impact:
- Antithrombotic therapy could be a novel strategy to improve cancer outcomes.
- Anticoagulation may enhance survival rates in specific cancer patient populations.
- Further research into anticoagulation's role in cancer is warranted.